⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CBIO News
Crescent Biopharma, Inc. Common Stock
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
globenewswire.com
CBIO
Vibrant Capital Launches to Scale AI in the Real Economy
prnewswire.com
CBIO
CitrusBurn Product Information Updated as Consumer Interest in Citrus-Based Weight Management Supplement Disclosures Grows in 2026
globenewswire.com
CBIO
CaseBioscience® Launches CaseCryo® CTG DMSO and CaseStor® HSS at ATW 2026, Advancing Next-Generation Biopreservation for Cell Therapy
prnewswire.com
CBIO
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
CineBlock Launches Entertainment Investment Marketplace, Opening Film and Media Ownership to Everyday Fans
accessnewswire.com
CBIO
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
globenewswire.com
CBIO
Crescent Biopharma Announces Grants of Inducement Awards
globenewswire.com
CBIO
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
globenewswire.com
CBIO